News - The readers of Condé Nast Traveler have spoken: in the latest edition of the prestigious U.S. magazine’s annual ranking, to be published in November, Québec City was voted 10th best destination in the world, 3rd best in North America and No. 1 in Canada.
News - To encourage the development of technological businesses in Québec, the Anges Québec private investors network has entered into a privileged partnership agreement with Valeo Management, MSBi Valorisation, SOVAR and Univalor, technology transfer and commercialization companies derived from university research in Québec. This agreement will favour the sharing of expertise and the pooling of resources and financial and business networks to support innovative seed companies that commercialize technologies derived from university research.
News - The first trailer for the game Assassin's Creed IV Freedom Cry is finally out! Produced entirely in Quebec, it is now available on line and will be accessible via live stream from theAssassin's Creed IV Black Flag game in stores starting October 29. The Assassin's Creed IV Freedom Cry trailer was created with the collaboration of partners in Quebec City:Sunny Side Up Creative did the conception and production work, while Squeeze Studio Animation created the 3D scenes and participated in the conception. SAGA produced the live action scenes, and Studio Elément took care of post-production.
News - Exfo Inc., the Quebec City-based designer and maker of high-tech telenetworking equipment, says its expanding wireless business will deliver more growth over the next year and the company’s overall cost base will shrink by a further $9 million U.S.
News - TeraXion, a leader in the development and manufacturing of optical components designed for very-high-speed networks, and Esterline CMC Electronics (CMC), a leader in the design and manufacturing of avionics systems, are partnering to design next-generation transceivers. Through this partnership, CMC will benefit from TeraXion's expertise in designing high-speed, high-volume components for fiber-optic telecommunications. In turn, TeraXion will benefit from CMC's expertise in the design of high-reliability avionics components, to better meet the ever-increasing reliability requirements of civil optical communications systems.
News - Atrium Innovations announces that it has acquired 70% of the outstanding shares of Mucos Pharma CZ s.r.o. , the exclusive distributor of Wobenzym® products in Central and Eastern Europe. Over the past few years, the solidly established Mucos CZ has successfully distributed Wobenzym® products primarily in Russia, Czech Republic and Slovakia. This controlling interest in Mucos CZ reflects the strategic importance of Central and Eastern European markets to Atrium in reference to Wobenzym’s potential and the potential for future cross-selling opportunities particularly in Russia.
News - The conclusions of a new study, presented in Québec City as part of the 7th Scientific Meeting of the International Society of Nutrigenetics and Nutrigenomics, show a favourable link between maple syrup and metabolic health. The in vivo study, conducted by a team led by Dr. André Marette, who holds a Ph. D. from Université Laval, aimed to compare the glycemic index of maple syrup to that of other sweetening agents, including brown rice syrup, corn syrup, agave syrup, honey, molasses and benchmark solution (dextrose), on healthy animals.
News - Merck Canada announced yesterday the allocation of a total of $16 million in grants to Quebec’s four faculties of medicine. McGill, along with Université de Montréal, Université de Sherbrooke and Université Laval will each receive $4 M to support health research with a translational component conducted in areas of unmet medical need.
News - DreamWorks Animation and Blizzard Entertainment will take part in Quebec City’s Mini Pixel new master classes in animation. The side event will be held at the Loews Hôtel Le Concorde on Tuesday, October 29 during Cartoon Connection Canada, an international convention of animation and video game professionals.
News - Researchers from Université Laval’s Faculty of Medicine and CHU de Québec have shown that it is possible to treat venous ulcers unresponsive to conventional treatment with wound dressings made from human skin grown in vitro. A study published recently in the journal Advances in Skin and Wound Care demonstrates how this approach was successfully used to treat venous lower-extremity ulcers in patients who had been chronically suffering from such wounds.